Phosphodiesterase Inhibitors Market Analysis By Industry Size, Share, Revenue Growth, Development And Demand Forecast 2028
Research Nester published a report titled “Phosphodiesterase Inhibitors Market: Global Demand Analysis & Opportunity Outlook 2028”which delivers a detailed overview of the phosphodiesterase inhibitors market in terms of market segmentation by drug class, type, application and by region.
Further, for the
in-depth analysis, the report encompasses the industry growth drivers,
restraints, supply and demand risk, market attractiveness, BPS analysis, and
Porter’s five force model.
Phosphodiesterase
(PDE) inhibitors are termed as therapeutic agents that target PDE isoenzymes
and prevents the metabolism of the secondary messengers (cyclic adenosine
monophosphate, cyclic guanosine monophosphate) and prolonging the biological
effect. Theophylline and papaverine are the two broadly used non-selective
phosphodiesterase enzyme inhibitors and are widely accepted to treat various
diseases such as cardiovascular, respiratory, and erectile dysfunction.
Get Exclusive Sample Report Copy Of This Report @ https://www.researchnester.com/sample-request-2634
The global
phosphodiesterase inhibitors market is segmented by application into
respiratory disease, erectile dysfunction, vascular disease, diabetes and
others, out of which, the erectile dysfunction sub-segment is anticipated to
hold leading shares in the phosphodiesterase inhibitors market on the back of
the growing concern for the increasing number of patients that have erectile
dysfunction disease and the growing incidences of diseases such as diabetes
mellitus, testosterone deficiency, prostate cancer, obesity, hypertension,
hyperlipidemia. It is to be noted here that consumption of certain medicines
and substance abuse are some of the major factors that can lead to erectile
dysfunction, thereby raising the need for the greater application of
phosphodiesterase inhibitors in the treatment of erectile dysfunction.
Regionally, the
phosphodiesterase inhibitors market is segmented into five major regions
including North America, Europe, Asia Pacific, Latin America, and the Middle
East & Africa region. North America is projected to account for the highest
share of the phosphodiesterase inhibitors market throughout the forecast period
on account of factors such as the presence of large pharmaceutical companies
and increasing lifestyle changes are contributing to the phosphodiesterase
inhibitors market growth in the region.
Rising Prevalence Of Chronic Disease And Erectile Dysfunction
Factors such as rising
expenditure for the treatment of chronic diseases, coupled with escalating the
prevalence of erectile dysfunction and growing concern for the chronic diseases
such as heart disease, stroke, diabetes, and prediabetes amongst individuals
worldwide are estimated to drive the market over the forecast period.
However, potential
drug interactions of PDE inhibitors, side-effects associated with PDE
inhibitors, and the launch of generics are expected to operate as key restraint
to the growth of phosphodiesterase inhibitors market over the forecast period.
This report also
provides the existing competitive scenario of some of the key players of the
phosphodiesterase inhibitors market which includes company profiling of Bayer
AG (ETR: BAYN), Eli Lilly and Co. (ETR: BAYN), GlaxoSmithKline Plc (LON: GSK),
Pfizer Inc. (NYSE: PFE), Vivus Inc (OTCMKTS: VVUSQ), AstraZeneca plc (LON:
AZN), and Celgene Corporation (NASDAQ: CELG). The profiling enfolds key
information of the companies which encompasses business overview, products and
services, key financials, and recent news and developments. On the whole, the
report depicts a detailed overview of the phosphodiesterase inhibitors market
that will help industry consultants, equipment manufacturers, existing players
searching for expansion opportunities, new players searching possibilities, and
other stakeholders to align their market-centric strategies according to the
ongoing and expected trends in the future.
Get Exclusive Sample Report Copy Of This Report @ https://www.researchnester.com/sample-request-2634
About Research Nester
Research Nester is a
leading service provider for strategic market research and consulting. We aim
to provide unbiased, unparalleled market insights and industry analysis to help
industries, conglomerates and executives to take wise decisions for their
future marketing strategy, expansion and investment etc. We believe every
business can expand to its new horizon, provided a right guidance at a right
time is available through strategic minds. Our out of box thinking helps our
clients to take wise decision so as to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. +1 646 586 9123
U.K. +44 203 608 5919
Comments
Post a Comment